The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline.

Haifeng Chen,Xiaoning Sheng,Caimei Luo,Ruomeng Qin,Qing Ye,Hui Zhao,Yun Xu,Feng Bai,Alzheimer’s Disease Neuroimaging Initiative
DOI: https://doi.org/10.1186/s40035-020-00201-6
2020-01-01
Translational Neurodegeneration
Abstract:BACKGROUND:Subjective cognitive decline (SCD) is a preclinical stage along the Alzheimer's disease (AD) continuum. However, little is known about the aberrant patterns of connectivity and topological alterations of the brain functional connectome and their diagnostic value in SCD. METHODS:Resting-state functional magnetic resonance imaging and graph theory analyses were used to investigate the alterations of the functional connectome in 66 SCD individuals and 64 healthy controls (HC). Pearson correlation analysis was computed to assess the relationships among network metrics, neuropsychological performance and pathological biomarkers. Finally, we used the multiple kernel learning-support vector machine (MKL-SVM) to differentiate the SCD and HC individuals. RESULTS:SCD individuals showed higher nodal topological properties (including nodal strength, nodal global efficiency and nodal local efficiency) associated with amyloid-β levels and memory function than the HC, and these regions were mainly located in the default mode network (DMN). Moreover, increased local and medium-range connectivity mainly between the bilateral parahippocampal gyrus (PHG) and other DMN-related regions was found in SCD individuals compared with HC individuals. These aberrant functional network measures exhibited good classification performance in the differentiation of SCD individuals from HC individuals at an accuracy up to 79.23%. CONCLUSION:The findings of this study provide insight into the compensatory mechanism of the functional connectome underlying SCD. The proposed classification method highlights the potential of connectome-based metrics for the identification of the preclinical stage of AD.
What problem does this paper attempt to address?